As a new type of foreign trade service provider driven by both technological transformation and foreign trade services, HiSiaddi has established a "1+2+3+4=1" service system and can supply raw materials from well-known original manufacturers of polygonum cuspidatum extract.
As a foreign trade service provider with R&D capabilities, HiSiaddi has conducted multiple rounds of on-site inspections of polygonum cuspidatum extract manufacturers based on extensive market experience, developing objective and in-depth understanding of different brands. We regularly analyze various polygonum cuspidatum extract manufacturers for clients to assist with matching suitable products. The following is a brand selection recommendation case.
For more comparative analysis of brands and specifications, please contact HiSiaddi customer service.
The purchaser is VitaSelect, a premium health pharmaceutical company headquartered in Bavaria, Germany. With 22 years of R&D and production experience in premium dietary supplements and hospital-grade antioxidant health products for German, Austrian and Swiss German-speaking markets, its products are sold at premium organic drugstore chain DM and private clinic chains across Switzerland. All product lines comply with five core access standards: European Pharmacopoeia EP, EC396 pesticide residue control, REACH registration, German LFBG food regulations, and Kosher Jewish certification. Its two flagship product lines are compound resveratrol tablets and oral antioxidant liquids, for which polygonum cuspidatum extract serves as the core functional raw material. The group has long sourced pharmaceutical-grade polygonum cuspidatum extract from local Swiss raw material manufacturers, qualifying as a typical mid-to-high-end buyer rejecting low-grade generic raw materials and prioritizing manufacturer quality control and batch consistency.
Driven by continuous price inflation for native European plant extracts and extended lead times exceeding 90 days at Swiss manufacturers, the client launched a localized Chinese raw material comparison and selection project with three core customized polygonum cuspidatum extract specifications required:
1. Full-spectrum compound extract: trans-resveratrol 10% + polydatin 25% for tablet mass production
2. 98% high-purity resveratrol monomer powder for premium oral liquid formulations
3. Aqueous modified 20% resveratrol extract for effervescent tablet manufacturing All product categories must meet emodin ≤0.3%, EU-standard screening for 234 pesticide residues, provision of CNAS English COAs and full REACH supporting documentation, alongside powder physical properties compatible with Germany’s automatic tableting and low-temperature emulsification production lines.
The client initially independently contacted five leading domestic polygonum cuspidatum extract manufacturers: CONBA Phytochemistry Division, Changsha Shanghe Bio, Shaanxi Huike Plant, Xi’an Sinuote Bio and Hunan Huacheng Bio. However, brand selection deadlock emerged during research. Sales representatives at each factory exclusively promoted their own full product lines, refraining from malicious competitor defamation yet omitting objective explanations of competing brands’ product advantages and applicable scenarios. Unable to distinguish manufacturing process differences, specification strengths and compatible formulation scenarios across brands, the client received 8 different specification samples from five manufacturers with inconsistent indicator performance, powder physical properties incompatible with production lines, and partial samples testing borderline excessive pesticide residues. Testing expenses reached EUR 12,800, stalling brand selection for 45 days and delaying the scheduled new product launch. Recommended by industry peers at Germany’s Natural Raw Materials Association, the client fully entrusted HiSiaddi’s foreign trade team with plant extract brand research and raw material selection capabilities to conduct neutral horizontal disassembly of product portfolios and pros and cons across the five domestic manufacturers, screening two premium mid-to-high-end brands and finalizing three product specifications matching the client’s formulation requirements.
The client conducted one-on-one communication with five leading domestic polygonum cuspidatum extract manufacturers, all formal mid-to-large plant extract enterprises holding GMP and ISO22000 certifications without malicious competitor denigration. However, all sales outreach was limited to self-product promotion, creating the primary barrier to client selection. Basic brand profiles and promotional characteristics are organized below:
1.
Zhejiang CONBA Phytochemistry (Leading Pharmaceutical Group Brand in China) Backed by listed pharmaceutical enterprise CONBA’s proprietary traditional Chinese medicine extraction workshops, it is China’s sole polygonum cuspidatum raw material manufacturer recorded in official Chinese herbal extract pharmacopoeia filings. Its core strengths lie in exceptional batch stability of pharmaceutical-grade full-spectrum extracts, proprietary standardized GAP polygonum cuspidatum planting bases with complete raw material traceability, and full production workflows governed by pharmaceutical GMP standards. Its flagship spot specifications are 10% compound full-spectrum resveratrol extract and 98% high-purity monomer, with sales presentations exclusively focusing on compatibility with pharmaceutical tablets without elaborating on Changsha Shanghe’s aqueous modification technology or Shaanxi Huike’s mass-production cost advantages.
2.
3.
Changsha Shanghe Bio (Southern Benchmark for Refined Customization) A high-tech Hunan plant extract enterprise with proprietary polygonum cuspidatum planting bases across Yunnan, Guizhou and Sichuan provinces. Its core proprietary technology combines low-temperature segmented extraction and cyclodextrin aqueous modification, with three flagship product series: customized compound ratio extracts, graded aqueous modified extracts and 98% monomers. It specializes in non-standard customized modified raw materials compatible with health supplement oral liquids and effervescent tablet formulations. Sales representatives prioritize self-developed aqueous product lines without comprehensive introduction of CONBA’s strengths in pharmacopoeia compliance and batch stability, nor commentary on Huike’s mass-production cost advantages.
4.
5.
Shaanxi Huike Plant (Northwestern Mass Production Leader) Leveraging natural polygonum cuspidatum resources in the Qinba Mountain range, it specializes in mass standardized generic raw materials with abundant spot inventory, flagship conventional full-spectrum extracts at 5% and 10% resveratrol with low mass-production costs and fast delivery, suitable for large-volume generic food-grade raw material applications. Sales focus exclusively on low-cost mass-produced in-house specifications without objective explanation of Shanghe’s aqueous modified raw material advantages in water solubility and formulation compatibility, or CONBA’s superior pharmaceutical-grade internal control standards.
6.
7.
Xi’an Sinuote Bio (Northwestern Small-Batch Customization Manufacturer) Comprehensive product portfolio covering ratio extracts and high-purity monomers with fast small-batch sampling and low minimum order quantities, alongside abundant spot specifications. However, production capacity for premium modified raw materials is limited. Sales fully promote all in-house spot products without horizontal comparison of leading manufacturers’ strengths in pesticide residue control and stable mass supply capacity.
8.
9.
Hunan Huacheng Bio (Self-Sufficient Raw Material Plant Extract Brand) Proprietary authentic medicinal herb planting gardens in Hunan with over 92% self-supplied raw materials, offering mid-tier specifications with outstanding cost performance. Flagship product: 10% food-grade full-spectrum resveratrol extract, while high-purity 98% monomers are outsourced for contract manufacturing. Sales only introduce cost advantages of mid-tier in-house products without mentioning proprietary refined manufacturing processes for high-purity monomers from leading competing brands.
10.
Client Pain Point Summary: Individual manufacturers only promote products from their own operational perspective. Lacking knowledge of China’s plant extract brand landscape, manufacturing processes and specification selection criteria, overseas clients cannot accurately match product specifications to their three end-product formulations when independently sourcing samples and conducting blind testing, incurring elevated testing costs and extended procurement lead times. A neutral third-party service provider HiSiaddi is required to deliver objective horizontal evaluation across all brands.
HiSiaddi established a plant extract technical selection team to compile product brochures, factory quality inspection reports, process documentation and overseas end-user case studies from all five brands. Combined with the client’s tablet, oral liquid and effervescent tablet manufacturing parameters and EU compliance standards, neutral cross-brand comparison was conducted across seven dimensions: raw material sources, manufacturing processes, product specifications, impurity control, powder physical properties, compliance supporting documentation and mass production compatible scenarios, with unbiased pros and cons outlined for each brand without favoritism toward any manufacturer.
Flagship Specifications: ① Pharmacopoeia-grade full-spectrum compound extract: trans-resveratrol 10% + polydatin 25% (specialized for pharmaceutical tablets) ② EP-grade 98% high-purity resveratrol monomer powder (raw material for pharmaceutical oral liquids) Strengths: All production lines aligned with both Chinese Pharmacopoeia and European EP Pharmacopoeia; internal emodin control ≤0.25%, exceeding the client’s 0.3% limit. Complete raw material traceability with full batch production records supplied with every shipment. Over years of consistent supply to China’s leading pharmaceutical enterprises, batch component fluctuation ≤±1%, with stable repose angle powder fully compatible with automatic tableting equipment. Weaknesses: No large-scale aqueous modification production lines; customized 20% aqueous specifications require dedicated production line reconstruction, incurring higher customized pricing and extended lead times, rendering it unsuitable for effervescent tablet mass production.
Flagship Specifications: ① Custom compound ratio full-spectrum extracts ② Cyclodextrin inclusion aqueous modified 20% resveratrol powder (effervescent tablet / solid beverage applications) ③ 98% high-purity resveratrol monomer Strengths: Proprietary low-temperature extraction and cyclodextrin modification technology enabling complete cold water solubility with zero precipitate, perfectly matching effervescent tablet formulations. All pesticide residue screening complies with EU EC396 standards, with rapid provision of full English REACH and Kosher supporting documentation alongside flexible small-batch customization. Weaknesses: Mass production capacity for pharmacopoeia-grade full-spectrum compound extracts lags behind CONBA, creating extended lead times for large-volume continuous orders.
Flagship Specification: Conventional food-grade full-spectrum extracts with 5% and 10% resveratrol Strengths: Large-scale mass production with abundant spot inventory and the lowest procurement costs, suitable for low-tier generic health supplement formulations. Weaknesses: No proprietary production lines for 98% high-purity monomers or aqueous modified product lines; conventional products universally test 0.4%–0.6% emodin, failing the client’s pharmaceutical-grade internal control indicators and eliminating it from premium brand shortlists.
Flagship Specifications: Full-spectrum ratio extracts and all purity grades of monomers Strengths: Fast sampling response and low minimum order quantities. Weaknesses: Premium high-purity monomers are predominantly outsourced for contract manufacturing, leading to excessive batch indicator fluctuation. Internal pesticide residue control standards fail EU 234-item full screening requirements, disqualifying it from German market entry and client recommendation.
Flagship Specification: 10% food-grade full-spectrum resveratrol extract Strengths: Proprietary raw material planting bases delivering moderately priced conventional mid-tier raw materials. Weaknesses: No proprietary production lines for 98% high-purity monomers or aqueous modified raw materials, all outsourced for repackaging with incomplete compliance supporting documentation, failing German drug administration filing requirements and eliminating it from mid-to-high-end procurement shortlists.
Combined with differentiated demand across the client’s tablet, oral liquid and effervescent tablet product lines, Huike, Sinuote and Huacheng were eliminated for failing premium internal control standards. Two leading domestic mid-to-high-end brands – CONBA Phytochemistry and Changsha Shanghe Bio – were finalized, with three fixed product specifications matched one-to-one to the client’s three finished product production lines:
1. CONBA Pharmacopoeia-Grade Full-Spectrum Compound Extract (trans-resveratrol 10% + polydatin 25%) → Sustained-release tablet mass production (leveraging CONBA’s pharmaceutical-grade quality control to resolve tablet filling blockages and uneven component content risks)
2. CONBA EP-Grade 98% High-Purity Resveratrol Monomer Powder → Premium Antioxidant Oral Liquid Formulations (ultra-low impurities eliminating precipitate separation risks during high-temperature emulsification)
3. Shanghe Bio Cyclodextrin Inclusion Aqueous Modified 20% Resveratrol Extract → Dedicated Effervescent Tablet Production Line (proprietary aqueous modification technology delivering complete cold water solubility without residue, fully compatible with low-temperature effervescent granulation workflows)
HiSiaddi coordinated 50g precision customized samples from both brands for unified full-dimensional testing at the client’s German VitaSelect R&D laboratory, covering active ingredient content, emodin, 234 pesticide residues, heavy metals, residual solvents, powder flowability and water solubility. Three rounds of testing confirmed all three product specifications outperformed the client’s internal control standards: CONBA’s two pharmaceutical-grade raw materials tested 0.21%–0.24% emodin, while Shanghe’s aqueous modified powder achieved 100% cold water solubility with zero flocculent precipitate after 72 hours static storage, with repose angle and hygroscopy fully compatible with Germany’s automatic production lines.
The client immediately finalized its initial procurement order: 2.8 tons of CONBA full-spectrum compound powder, 0.9 tons of CONBA 98% high-purity monomer and 1.3 tons of Shanghe aqueous modified powder, totaling 5 tons split into two shipments delivered via thermostatically controlled vacuum aluminum foil packaging to bonded warehouses in Hamburg, Germany. Post raw material delivery and mass production launch, the tablet, oral liquid and effervescent tablet production lines operated stably for 28 consecutive days without feed blockages, stratification or unqualified component content failures. The delayed German autumn and winter new product line successfully launched across nationwide pharmacies.
Compared with the client’s original Swiss imported raw materials, localized Chinese procurement delivered a 28client immediately signed an annual long-term framework procurement agreement for 19 tons, with monthly split deliveries across 12 batches for all three specifications. Subsequent demand arose for low-irritation customized polygonum cuspidatum extract for German children’s oral liquids, all sourced via HiSiaddi with on-demand customization and supply coordinated from CONBA and Shanghe.
The following year, relying on stable, high-quality localized raw materials, VitaSelect expanded its market footprint into Austria and Luxembourg’s premium health product sectors and placed new procurement orders for refined polygonum cuspidatum extract for medical aesthetic skincare. HiSiaddi continued to adjust product indicators and supply full EU compliance documents on demand via its CONBA and Shanghe brand resource network. Endorsed by this fixed-supply partnership with a well-known German pharmaceutical enterprise, both CONBA and Shanghe simultaneously secured long-term orders from multiple mid-to-high-end health brands in the Netherlands and Sweden, escaping the vicious cycle of low-price homogenized competition among single manufacturers. HiSiaddi upgraded its domestic plant extract brand database, establishing segmented product selection archives categorized by pharmaceutical grade, premium food grade and cosmetic grade, and continues to provide neutral brand selection services for mid-to-high-end clients across Europe and America.
Driven by profit-oriented business models, domestic plant extract manufacturers’ sales teams only promote their own products and lack motivation to objectively introduce competitive brands’ technical strengths. While mid-to-high-end overseas clients are proficient in their domestic pharmacopoeias and finished product manufacturing processes, they lack awareness of China’s plant extract brand hierarchy and the respective advantages and disadvantages of each manufacturer’s production technology. Independent one-on-one communication with manufacturers easily leads to one-sided brand selection, wasted testing samples and delayed project timelines.
Breaking the traditional foreign trade model limited to single-brand agency sales, HiSiaddi acts as a neutral third-party technical service provider. Based on clients’ formulation requirements and overseas regulatory standards, it horizontally dissects full product portfolios of multiple brands, selects optimal matching brands and specifications objectively, and bridges the information gap between overseas clients and domestic multi-brand manufacturers. This not only helps mid-to-high-end overseas clients smoothly implement localized procurement from China, but also empowers premium domestic high-end plant extract brands to break away from low-price competition and deeply penetrate Europe’s high-end natural raw material supply chains.
For more comparative analysis of brands and specifications, please contact HiSiaddi customer service.
+86-13120989737 
info@hisiaddi.com 
English
